the court ruled that by

advertising its drug interaction software, the

defendant pharmacy voluntarily assumed a duty

to use its computer technology with due care. The

pharmacy technician had overridden the drug

interaction between tranylcypromine (Parnate ®)

and clemastine fumarate/phenylpropanolamine

hydrochloride (Tavist D ®) that the system detected

from the patient’s medication profile. The patient

committed suicide after suffering a stroke from the

combination.